Press "Enter" to skip to content

Tag: SARS-CoV-2

‘Telework’ Can Be a Life Changer

If you are the family member of someone who’s highly immunocompromised, and you’re not able to protect yourself from infection in your workplace and your employer is insisting that you come back and work in an office where people have now shifted to the mindset that [COVID-19] is not that big a deal, if someone gets [sick] and you bring that home, that can be catastrophic.

Comments closed

Long COVID still has no cure — so these patients are turning to research

When Lisa McCorkell got COVID-19 in March 2020, her symptoms were mild. Her physicians told her to isolate from others and that she would recover in a few weeks. But the weeks stretched into months and McCorkell, who was working on a master’s degree in public policy at the University of California, Berkeley, started having debilitating and bewildering symptoms: fatigue, dizziness and shortness of breath. Previously an avid runner, McCorkell found her heart racing from simple efforts.

She struggled to find an explanation, and soon realized that her physicians didn’t know any more about her condition than she did. To complicate matters, the limited availability of high-quality testing for the coronavirus SARS-CoV-2 in the early days of the pandemic left many of her doctors wondering whether her symptoms were really due to COVID-19 at all. “I didn’t have health-care providers that took me seriously,” McCorkell says. “That largely pushed me out of the health-care system.”

McCorkell turned instead to those who were experiencing the same puzzling symptoms and frustrations, joining a support group for people with what would eventually be called long COVID. As they compared notes, McCorkell and a handful of others — many of whom had research experience — realized that the information they were sharing might be helpful not only for those with long COVID, but also for those looking to study the condition. So, they founded a non-profit organization, called the Patient-Led Research Collaborative (PLRC), to design, provide advice on and even fund basic and clinical research into long COVID and other chronic illnesses.

Comments closed

Paxlovid to no longer be provided to provinces for free

The Public Health Agency of Canada (PHAC) is no longer paying for an antiviral pill used to treat COVID-19.

The PHAC said it will no longer procure Paxlovid, which is intended to be used after being diagnosed with COVID, for provinces and territories.

“The provinces and territories are responsible for determining how best to implement and manage the available supply of COVID-19 therapeutics, including Paxlovid,” a spokesperson for Health Canada said in a statement.

Comments closed

Covid-19 Brings Down Healthy Life Expectancy In The U.K.

People born recently in England and Wales can expect to spend fewer years of their life in good health than those born over a decade ago, official figures show.

Covid-19, healthcare delays and an increase in long-term sickness are likely factors in this decline. But the Office of National Statistics figures also reflect deeper social issues like widespread inequality, say experts.

Comments closed

Video | Victorian children are diagnosed with long Covid

Victorian children as young as eight-years-old are being diagnosed with long Covid. Health experts warn it’s becoming more common, putting further pressure on the state’s health system.

Comments closed

COVID-19 research: Study reveals new details about potentially deadly inflammation

A recent USC study provides new information about why SARS-CoV-2, the virus behind the COVID-19 pandemic, may elicit mild symptoms at first but then, for a subset of patients, turn potentially fatal a week or so after infection. The researchers showed that distinct stages of illness correspond with the coronavirus acting differently in two different populations of cells.

The study, published in Nature Cell Biology, may provide a roadmap for addressing cytokine storms and other excessive immune reactions that drive serious COVID-19.

The team found that when SARS-CoV-2 infects its first-phase targets, cells in the lining of the lung, two viral proteins circulate within those cells—one that works to activate the immune system and a second that, paradoxically, blocks that signal, resulting in little or no inflammation.

Comments closed

Number hospitalized with COVID-19 in B.C. hits new low for 2024 in latest update

The number of patients with COVID-19 in B.C. hospitals declined to its lowest level of 2024 in the latest data update from the B.C. Centre for Disease Control.

There were 133 test-positive patients in provincial hospitals as of Thursday, according to the BCCDC. The last published update to show a total lower than that was in August of last year, when the BCCDC reported just 76 patients hospitalized.

This week’s hospitalized population is less than half of what it was around this time last year. The final published update of March 2023 showed 294 patients in B.C. hospitals.

Comments closed

Mask mandate to be lifted at N.L. hospitals Monday

If you’re headed to the hospital on Monday, you won’t need to wear a mask as Newfoundland and Labrador Health Services has updated its masking guidelines.

Masking had been required for patients and visitors at health-care facilities since February, but will no longer be required as of Monday, according to NL Health Services.

People who are seeking care and showing symptoms of viruses like COVID-19 will still be required to wear a mask. They can wear their own medical mask to the facility — but not a cloth mask — or get one on-site.

Comments closed

Cost of private Covid jabs risks widening health inequalities, experts warn

Experts and patient groups have warned that the high cost of private Covid vaccinations could exacerbate health inequalities and leave those more at risk from the virus without a vital line of defence.

Both high street chain Boots and pharmacies that partner with the company Pharmadoctor are now offering Covid jabs to those not eligible for a free vaccination through the NHS, with the former charging almost £100 for the Pfizer/BioNTech jab.

While Pharmadoctor says each pharmacy sets its own prices, it suggests the Pfizer/BioNTech jab will set customers back £75-£85, while the latest Novavax jab will cost about £45-£55.

Comments closed

New Data: Long COVID Cases Surge

Experts worry a recent rise in long COVID cases — fueled by a spike in winter holiday infections and a decline in masking and other measures — could continue into this year.

A sudden rise in long COVID in January has persisted into a second month. About 17.6% of those surveyed by the Census Bureau in January said they have experienced long COVID. The number for February was 17.4.

Compare these new numbers to October 2023 and earlier, when long COVID numbers hovered between 14% and 15% of the US adult population as far back as June 2022.

Comments closed

Do you need a spring COVID-19 vaccine? Research backs extra round for high-risk groups

New guidelines suggest certain high-risk groups could benefit from having another dose of a COVID-19 vaccine this spring — and more frequent shots in general — while the broader population could be entering once-a-year territory, much like an annual flu shot.

Medical experts told CBC News that falling behind on the latest shots can come with health risks, particularly for individuals who are older or immunocompromised.

“Even when the risk of infection starts to increase, the vaccines still do a really good job at decreasing risk of severe disease,” said McMaster University researcher and immunologist Matthew Miller.

Comments closed

Almost one-in-five suffering from long COVID

A study of more than 11,000 Australians who tested positive to COVID-19 in 2022 has revealed almost one-in-five were still experiencing ongoing symptoms three months after their initial diagnosis, according to new research from The Australian National University (ANU).

The study was conducted in Western Australia (WA), with participants drawn from the almost 71,000 adults who tested positive to COVID-19 in WA between 16 July 2022 and 3 August 2022.

Lead researcher, Dr Mulu Woldegiorgis, said the results show the risk of developing long COVID from the Omicron variant is higher than previously thought.

Comments closed

Omicron linked to more long COVID-19 cases: study

The Omicron coronavirus variant could be causing more cases of long COVID than earlier versions of the disease, scientists say.

A study of more than 11,000 Western Australians infected in 2022 found almost one in five continued to suffer symptoms three months after they initially tested positive.

Epidemiologist Mulu Woldegiorgis said the findings show the Omicron variant puts patients at greater risk of developing long COVID than previously thought.

“It is more than double the prevalence reported in a review of Australian data from earlier in the pandemic, and higher than similar studies done in the UK and Canada,” she said on Thursday.

Comments closed

Anti-COVID mandate protester found not guilty of criminal charges

WARNING: This story contains offensive and racist language.

A Kelowna man charged with causing a disturbance after yelling at a security guard at a vaccine clinic has been found not guilty by a B.C. judge.

Bruce Orydzuk, 60, was captured on video repeatedly yelling at the guard, who was wearing a turban. The guard had asked him to leave the property of a COVID-19 vaccine clinic in July 2021.

Comments closed

Masking policy updated by Huron Perth Healthcare Alliance

Huron Perth Healthcare Alliance (HPHA) is updating its masking policy.

“Based upon the most recent Public Health Ontario guidance, updates will be made…” read a release from the organization.

Effective immediately, masking will be “welcomed but no longer required,” in many clinical areas of HPHA hospital sites with the exception of emergency departments where masking is still required.

Masking will also still be required for anybody who has symptoms of respiratory infection such as cough, fever and sore throat. If you’re accompanying somebody with symptoms, you must also wear a mask.

Comments closed

Study: Kids with COVID but no symptoms play key role in household spread

A study today in Clinical Infectious Diseases conducted across 12 tertiary care pediatric hospitals in Canada and the United States shows that asymptomatic children with COVID-19, especially preschoolers, contribute significantly to household transmission.

The researchers discovered that 10.6% of exposed household contacts developed symptomatic illness within 14 days of exposure to asymptomatic test-positive children, a rate higher than expected.

“We determined that the risk of developing symptomatic illness within 14 days was 5 times greater among household contacts of asymptomatic SARS-CoV-2–positive children,” the authors wrote.

They also found that 6 of 77 asymptomatic SARS-CoV-2–infected children during a 3-month follow-up developed long COVID, or 7.8% of them.

Comments closed

3 more COVID deaths in New Brunswick, 4 youth among flu hospitalizations

Three more New Brunswickers have died from COVID-19, while no new influenza deaths have been reported, and hospitalizations for both viruses have decreased, updated data from the province Tuesday shows.

A child under four, and three youth aged five to 19 are among those hospitalized by the flu between March 10 and March 16, according to the Respiratory Watch report.

“COVID-19 activity remains moderate; some indicators (number of cases, percent positivity, and hospitalizations) decreased slightly during the current reporting period,” it says.

Influenza activity “slightly decreased” during the reporting week.

Of the three people who died, one was aged 45 to 64 and the other two were aged 65 or older.

Comments closed

Video | Elle espère guérir de la COVID longue depuis 4 ans

Family physician Caroline Grégoire suffers from post-COVID-19 syndrome [long COVID]. She shares her symptoms and her life’s struggle over the past four years: to manage her energy. She deplores the government’s lack of help and says her chronic fatigue has not always been taken seriously, or even invalidated, by healthcare workers.

Comments closed